Tomorrow

San Jose, CA (PRWEB) December 20, 2011 Jon Bruner, Forbes New Product Editor, spent last summer preparing for and then enjoying a rather unusual reporting assignment: a trip to the bottom of the Grand Canyon, on foot, followed by a black-tie dinner next to a remote waterfall. He evaluated several GPS Receivers and Solar Chargers, including the Suntactics solar charger, as part of his trip. He reported his conclusions in a December 15th article entitled ?Neat Stuff for the Outdoor Type: Hiking Equipment Made in America, GPS Receivers and Solar Chargers?. ?Most practical, portable solar panels don?t produce enough electricity to power your devices as you use them. The main drawback of the GoalZero system is that it?s not terribly compact and involves a few separate components, which can make for trouble when you?ve got a full pack. Some alternatives merge all of these components into a single device, like Brunton?s Restore or the Joos Orange, both of which are bulkier panels that i...

Pittsburgh, PA (PRWEB) December 22, 2011 Celsense, Inc., announced today that it has received a Notice of Allowance for US Patent Application 10/586,015 with claims covering its MRI cell tracking product, Cell Sense. Cell Sense is a perfluorocarbon tracer agent used to label cells ex vivo, making them detectable in vivo after transplantation using magnetic resonance imaging (?MRI?). Invented by Eric Ahrens at Carnegie Mellon University, Cell Sense can be used to non-invasively image the administration, migration, and persistence of cells transplanted for therapeutic or diagnostic purposes using MRI. The use of Cell Sense was first reported in the journal Nature Biotechnology in 2005. Cell Sense is currently available for use in preclinical research and human clinical trials. The first clinical use of Cell Sense is in combination with an autologous dendritic cell vaccine used to treat colorectal cancer; the trial was authorized by the US FDA in May of 2011. It is conte...